Medtronic (MDT) Other financing activities (2014 - 2026)

Medtronic has reported Other financing activities for 13 years, with the latest figure at $478.0 million in Q2 2026.

• Quarterly Other financing activities rose 270.71% year-over-year to $478.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $538.0 million (up 392.39% YoY) and the FY2026 annual result came in at $538.0 million, up 392.39% from the prior year.
• Other financing activities advanced to $478.0 million in Q2 2026 per MDT's latest filing, from -$5.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $478.0 million in Q2 2026 and troughed at -$719.0 million in Q1 2023.
• A 5-year average of $8.4 million and a median of -$5.0 million in 2025 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2023: Other financing activities soared 6925.0% in 2022, then sank 11883.33% in 2023.
• Over 5 years, Other financing activities stood at $170.0 million in 2022, then decreased by 5.29% to $161.0 million in 2023, then slumped by 130.43% to -$49.0 million in 2024, then soared by 89.8% to -$5.0 million in 2025, then surged by 9660.0% to $478.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $478.0 million, -$5.0 million, and -$5.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.